Showing results (1521-1530 of 5,837) with videos related to

Sort By:
Pageof 584
Drug Design, Development and Therapy|March 29, 2016
Amsacrine analog-loaded solid lipid nanoparticle to resolve insolubility for injection delivery: characterization and pharmacokineticsYi-Ping Fang, Chih-Hung Chuang, Pao-Chu Wu, et al.
Drug Design, Development and Therapy|March 30, 2016
Celastrol inhibits prostaglandin E2-induced proliferation and osteogenic differentiation of fibroblasts isolated from ankylosing spondylitis hip tissues in vitroYu-Cong Zou, Xian-Wen Yang, Shi-Guo Yuan, et al.
Drug Design, Development and Therapy|February 6, 2016
Dose comparison of conivaptan (Vaprisol®) in patients with euvolemic or hypervolemic hyponatremia--efficacy, safety, and pharmacokineticsBiff F Palmer, Amy D Rock, Emily J Woodward
Drug Design, Development and Therapy|May 21, 2016
Fungistatic activity of all-trans retinoic acid against Aspergillus fumigatus and Candida albicansElena Campione, Roberta Gaziano, Daniele Marino, et al.
Drug Design, Development and Therapy|March 2, 2016
Protective effect of fucoidan from Fucus vesiculosus on liver fibrosis via the TGF-β1/Smad pathway-mediated inhibition of extracellular matrix and autophagyJingjing Li, Kan Chen, Sainan Li, et al.
Drug Design, Development and Therapy|March 2, 2016
The clinicopathological significance and ethnic difference of FHIT hypermethylation in non-small-cell lung carcinoma: a meta-analysis and literature reviewXiaoyu Wu, Guannan Wu, Xuequan Yao, et al.
Drug Design, Development and Therapy|March 2, 2016
A network pharmacology approach to discover active compounds and action mechanisms of San-Cao Granule for treatment of liver fibrosisShizhang Wei, Ming Niu, Jian Wang, et al.
Drug Design, Development and Therapy|April 5, 2016
Naringenin-loaded solid lipid nanoparticles: preparation, controlled delivery, cellular uptake, and pulmonary pharmacokineticsPeng Ji, Tong Yu, Ying Liu, et al.
Drug Design, Development and Therapy|February 19, 2016
Profile of tofacitinib citrate and its potential in the treatment of moderate-to-severe chronic plaque psoriasisV Di Lernia, F Bardazzi
Drug Design, Development and Therapy|February 20, 2016
Targeting the D1-N-methyl-D-aspartate receptor complex reduces L-dopa-induced dyskinesia in 6-hydroxydopamine-lesioned Parkinson's ratsLu Song, Zhanzhao Zhang, Rongguo Hu, et al.
Pageof 584